Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,055 DKK | +2.65% | -0.48% | -4.64% |
21/05 | Genmab A/S completed the acquisition of ProfoundBio, Inc. | CI |
15/05 | Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation' | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.64% | 18.8B | |
+10.09% | 114B | |
+12.72% | 107B | |
-5.57% | 22.22B | |
-0.67% | 21.28B | |
-6.32% | 17.51B | |
-39.36% | 17.17B | |
+6.46% | 14.14B | |
+34.80% | 12.2B | |
+15.61% | 8.01B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Genmab Says Epcoritamab Drug Combination Shows 98% Overall Response Rate in Phase 1/2 Trial in Follicular Lymphoma